Patients with stage IV/locally recurrent TNBC who had received no more than two previous chemotherapy regimens for mTNBC were randomly allocated to gemcitabine @,@ mg/m ( @ ) and carboplatin area under the curve @ ( days @ and @ ) alone or GC plus iniparib @ mg/kg ( days @ , @ , @ , and @ ) every @ weeks .